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Objectives The aim of this study was to report the results of an international multicenter experience of cardiac magnetic
resonance imaging (MRI) evaluation of cardiac tumors in children, each with histology correlation or a diagnosis
of tuberous sclerosis, and to determine which characteristics are predictive of tumor type.
Background Individual centers have relatively little experience with diagnostic imaging of cardiac tumors in children, because
of their low prevalence. The accuracy of cardiac MRI diagnosis on the basis of a pre-defined set of criteria has
not been tested.
Methods An international group of pediatric cardiac imaging centers was solicited for case contribution. Inclusion
criteria comprised: 1) age at diagnosis 18 years; 2) cardiac MRI evaluation of cardiac tumor; and 3) histo-
logic diagnosis or diagnosis of tuberous sclerosis. Data from the cardiac MRI images were analyzed for
mass characteristics. On the basis of pre-defined cardiac MRI criteria derived from published data, 3
blinded investigators determined tumor type, and their consensus diagnoses were compared with histologic
diagnoses.
Results Cases (n  78) submitted from 15 centers in 4 countries had the following diagnoses: fibroma (n  30), rhab-
domyoma (n  14), malignant tumor (n  12), hemangioma (n  9), thrombus (n  4), myxoma (n  3), tera-
toma (n  2), and paraganglioma, pericardial cyst, Purkinje cell tumor, and papillary fibroelastoma (n  1,
each). Reviewers who were blinded to the histologic diagnoses correctly diagnosed 97% of the cases but in-
cluded a differential diagnosis in 42%. Better image quality grade and more complete examination were associ-
ated with higher diagnostic accuracy.
Conclusions Cardiac MRI can predict the likely tumor type in the majority of children with a cardiac mass. A comprehensive
imaging protocol is essential for accurate diagnosis. However, histologic diagnosis remains the gold standard,
and in some cases malignancy cannot be definitively excluded on the basis of cardiac MRI images
alone. (J Am Coll Cardiol 2011;58:1044–54) © 2011 by the American College of Cardiology Foundation
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August 30, 2011:1044–54 Magnetic Resonance Imaging Evaluation of Cardiac TumorsCardiac tumors in children are rare, with a reported inci-
dence ranging from 0.027% to 0.08% (1,2). Therefore, the
experience of individual centers is relatively small. Case
reports and small case series have suggested that cardiac
magnetic resonance imaging (MRI) is useful in the delin-
eation of the location, extent, and signal characteristics of
cardiac tumors and masses in children (3–7). On the basis of
our initial experience with 11 cases and a review of the
published data, we developed cardiac MRI-based diagnostic
criteria that predict tumor type (4). This project aimed to
evaluate the accuracy of the diagnostic criteria against a
cohort of cases with histologic diagnosis of cardiac
tumors as the reference standard and to create a registry
of pediatric cardiac masses with cardiac MRI data and
histologic diagnosis generated from a multi-institutional
experience. The term “cardiac tumor” will be used
throughout the report to encompass all cardiac masses.
See page 1055
Methods
Patients. This was a retrospective, multicenter study of
cardiac tumors. Investigators at the core laboratory (Chil-
dren’s Hospital Boston) solicited participation from an
international group of pediatric cardiac imaging centers.
Cases that met the following criteria were included:
1) patient age at diagnosis 18 years; 2) cardiac MRI
evaluation of cardiac tumor performed between 1998 and
November 2010; 3) histologic diagnosis or definitive diag-
nosis of tuberous sclerosis (on the basis of either revised
clinical diagnostic criteria established by the Tuberous
Sclerosis Consensus Conference [8] or genetic diagnosis of
tuberous sclerosis [9]); and 4) submission of de-identified
clinical, cardiac MRI, and pathology data. The following
cases were excluded: 1) technically inadequate cardiac MRI
data, including inability to analyze data at the core labora-
tory; and 2) inconclusive histologic diagnosis or the case did
not meet criteria for tuberous sclerosis diagnosis. The study
was approved by the Scientific Review Committee of the
Department of Cardiology and by the Children’s Hospital
Boston Committee on Clinical Investigation. Contributing
centers followed the policies of their respective institutional
review boards.
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identifying information was re-
moved at the contributing in-
stitutions, and each case was
assigned a unique study num-
ber. The submitting institution
completed a case information
form with demographic and
clinical data. This form, a copy
of the cardiac MRI and pathol-
ogy reports, and a digital copy
of the cardiac MRI study were
sent to the study coordinator
for review. The following de-
mographic and clinical infor-
mation were recorded: 1) center
name and location; 2) patient
demographic data at the time of
cardiac MRI (age, sex, weight,
height); 3) presenting signs/
symptoms; 4) mode of initial di-
agnosis (e.g., chest radiograph, echocardiogram); 5) pre-
cardiac MRI diagnosis of likely tumor type; 6) date of
cardiac MRI; 7) cardiac MRI technical data (e.g., scanner
type, radiofrequency coil, sedation type, MR sequences,
technical problems); 8) adverse events attributable or pos-
sibly attributable to cardiac MRI; 9) cardiac MRI diagnosis
of tumor type at contributing institution; 10) source of
tissue (e.g., tumor resection, open biopsy, transcatheter
biopsy); 11) histologic diagnosis; 12) treatment; 13) date of
latest follow-up; and 14) clinical status at latest follow-up.
Cardiac MRI image analysis. Cardiac MRI images were
first analyzed by a single investigator (R.S.B.) at the core
laboratory who was blinded to the histologic diagnosis.
The following tumor characteristics were recorded:
1) size; 2) location; 3) presence of pericardial or pleural
effusion; 4) hemodynamic impact of tumor; and 5) signal
characteristics on cine steady state free precession (SSFP)
imaging, pre- and post-contrast T1-weighted turbo (fast)
spin echo imaging (T1-TSE), T2-weighted turbo (fast)
spin echo imaging (T2-TSE), first pass myocardial per-
fusion imaging (FPP), and myocardial delayed enhance-
ment imaging (MDE). On each of these imaging se-
quences the following characteristics were recorded:
1) signal intensity ratio of the tumor relative to adjacent,
uninvolved myocardium as described by Kiaffas et al. (4);
2) homogenous or heterogeneous appearance; 3) whether
the tumor appeared well-circumscribed and/or intramyo-
cardial; 4) complete or incomplete examination for diag-
nosis of tumor type (complete examination was defined as
including the necessary imaging sequences required to
determine tumor type as defined in Table 1); and
5) image quality score (very good [sharply defined bor-
ders— excellent quality diagnostic information], good
[minimal blurring— good quality diagnostic information
Abbreviations
and Acronyms
ECG  electrocardiography
FPP  first pass
myocardial perfusion
MDE  myocardial delayed
enhancement
MRI  magnetic resonance
imaging
SSFP  steady state free
precession
T1-TSE  T1-weighted
turbo (fast) spin echo
T2-TSE  T2-weighted
turbo (fast) spin echo
TE  echo time
TR  repetition time
TSE  turbo (fast) spin
echowith definite diagnosis], fair [structures visible with
wr
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Magnetic Resonance Imaging Evaluation of Cardiac Tumors August 30, 2011:1044–54moderate blurring—able to establish diagnosis], poor
[structures visible but markedly blurred— diagnosis sus-
pected but not definite]) determined by an experienced
observer (R.S.B.). Nondiagnostic quality images were
excluded from analysis. However, images with fair or
poor quality were included if deemed interpretable. Echo
time (TE) and repetition time (TR) were recorded for
black blood images.
Diagnosis of tumor type. First, a diagnostic criteria table
as developed on the basis of review of the published data
Patient CharacteristicsTable 2 Patient Characteristics
Tumor Type n (%)
Age at Presentation
(yrs)
Age at Cardi
(yrs)
All diagnoses 78 (100) 0.8 (0–18.6) 3.1 (0–29)
Fibroma 30 (38) 0.4 (0–12.5) 1.7 (0–29)
Rhabdomyoma 14 (18) 0 (0–0) 0 (0–6.4
Tuberous sclerosis 3 (4)
Malignant* 12 (16) 14.5 (9.0–18.6) 14.2 (12.3–
Hemangioma 9 (12) 0 (0–13) 0 (0–12.
Thrombus 4 (5) 11 (7–14) 11.1 (7–14)
Myxoma 3 (4) (13.0–17.5) (13–18
Teratoma 2 (3) 0, 9† 0.1, 11.5
Paraganglioma 1 (1) 16.4 16.4
Papillary fibroelastoma 1 (1) 3 3
Pleuropericardial cyst 1 (1) 5 5
Purkinje cell tumor 1 (1) — 1.1
Values are n (%) or median (min–max). *Malignant tumors included osteosarcoma (n  3), lymph
Tumor Diagnosis Prediction TableTable 1 Tumor Diagnosis Prediction Table
Tumor Type Location SSFP T1 T1  Fat
Fibroma Intramyocardial, ventricular
septum or free wall*
  
Rhabdomyoma Intramyocardial or intracavitary,
attached to myocardium
  
Malignant Infiltrative† 
Vascular‡ Variable   
Thrombus Mural or intraluminal*   
Myxoma Typically left atrium but can be
in any chamber
  
Fibroelastoma Pedunculated, mobile
endocardial or valvular mass
  
Pleuropericardial
cyst
Right cardiophrenic angle *  
Purkinje cell tumor Ventricular myocardium * —*
Teratoma Intrapericardial (usually
compressing SVC and/or RA)

Lipoma§ Any chamber  * —*
*Either strongly supportive of or necessary for diagnosis. †Infitrative: 1) crossing an annular or tissu
growth through a large vessel such as the superior or inferior vena cava. ‡Vascular refers to tumo
§Lipoma was not tested, because no cases of biopsy-proven lipoma were included.
 iso- or hypointense; variable intensity; hyperintense; strongly hyperintense;
RA  right atrium; SSFP  steady state free precession; SVC  superior vena cava.ound cell tumor (n  1), melanoma (n  1), and medulloblastoma (n  1). †There were only 2 patients
MRA  magnetic resonance angiography; MRI  magnetic resonance imaging.and prior experience. The table was then tested on each case
by a consensus of 3 reviewers at the core laboratory who were
blinded to the histologic diagnosis (R.S.B., A.P., T.G.). The
suspected tumor type, presence or absence of imaging se-
quences necessary for diagnosis, and image quality were re-
corded for each case. After completion of the review process
and data analysis, minor modifications were made to the table,
and the final set of criteria are presented in Table 1.
Statistical analysis. Continuous variables were summa-
rized as median and range, and categorical variables were
I
Male
Prenatal
Diagnosis
Length of Follow-Up
(yrs)
Age at Last Follow-Up
(yrs)
51 (65) 13 (17) 1.9 (0.1–31.5) 8.3 (0.2–32)
20 (66) 1 (0.03) 5.6 (0.1–32.0) 8.3 (1.3–32.0)
8 (57) 7 (50) 1 (0.3–4.5) 1 (0.3–4.5)
9 (75) 0 (0) 1 (0.1–4.4) 14.3 (12.8–16.5)
4 (44) 5 (55) 1.7 (0.2–2.7) 2.4 (0.2–15.6)
4 (100) 0 (0) — —
1 (33) 0 (0) (0.5–3) (15–20)
2 (50) 0 (0) — —
1 (100) 0 (0) — —
1 (100) 0 (0) 0.75 3.75
1 (100) 0 (0) — —
1 (100) 0 (0) — —
 2), rhabdomyosarcoma (n  2), angiosarcoma (n  1), B-cell lymphoma (n  1), desmoplastic
T2 FPP MDE Other
 No*  (well-defined
border  dark core)*
Can be in an
atypical location
 No* —
 Variable  (if  then
heterogenous
appearance)
History of malignancy
 (variable) Strong*  (variable and
heterogenous)
Consider malignant tumor
 No* —* MDE sequence,
long inversion time
 No * Irregular, pedunculated,
mobile*
 No
* No  Smooth-walled and
well-defined
 No Ventricular arrhythmia*
No Multilocular bosselated
mass with solid and
cystic areas
 No 
within the heart; 2) involving both cardiac and extracardiac structures; or 3) appearance of linear
strong vascular supply, including hemangioma, malignant vascular tumors, and paraganglioma.
 fat saturation; FPP first pass myocardial perfusion; MDEmyocardial delayed enhancement;ac MR
)
18.6)
8)
)
†
oma (nSat
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August 30, 2011:1044–54 Magnetic Resonance Imaging Evaluation of Cardiac Tumorsdescribed with counts and percentages. Using chi-square or
Fisher exact test, the percentages of accurate diagnosis of
tumor type were compared to assess how image quality and
missing cardiac MRI image data influenced diagnostic
accuracy. All tests were performed with 2-sided type I error
rate of 0.05. Data analyses were performed with SAS
software (version 9.2, SAS Institute, Inc., Cary, North
Carolina).
Results
Patients and clinical presentation. Cases (n  90) were
submitted from an international group of 15 imaging
centers from 4 countries. Of those, 12 cases were excluded
either due to lack of histologic diagnosis (no biopsy or
resection performed, n  9) or nondiagnostic images (n  3).
he remaining 78 cases comprised the study cohort, and
heir characteristics are summarized in Table 2. Because of
he relatively young age of the cohort (median age 3 years at
ime of cardiac MRI), 73% of scans were performed under
eneral anesthesia or with sedation (Table 3). Several of the
ases included in this study have been previously published
4,5,10).
Mode of initial presentation included the following:
rrhythmia (n  29; 37%), fetal echocardiogram (n  13;
7%), murmur (n  12; 15%), incidental finding (n  11;
4%), and clinical symptoms, including respiratory dis-
ress (n  15; 19%), chest pain (n  6; 8%), fatigue (n 
; 5%), dizziness (n  2; 3%), and cyanosis (n  2; 3%).
ost (97%) diagnoses were confirmed by tumor histology
biopsy or resection) with the exception of 2 cases of
habdomyoma in patients who met diagnostic criteria for
uberous sclerosis. Among the patients with benign
umors (n  66), most (87%) underwent partial or
omplete tumor resection, whereas the others underwent
iopsy only (4 fibromas, 1 hemangioma, and 5 rhab-
omyomas). Follow-up information was available on 46
atients for variable lengths of time (Table 2). Most
atients with benign tumors were asymptomatic at last
ollow-up. However, there were 3 deaths among patients
ith benign tumors: 1 fibroma (perioperative death); 1
emangioma (perioperative death); and 1 rhabdomyoma
died awaiting heart transplantation). In addition, resid-
al postoperative morbidity included ventricular dysfunc-
ion (n  3), arrhythmias (n  3), and valve regurgitation
n  3). Of the 9 patients with malignant tumors and
ollow-up information, 7 either had residual symptoms
n  1), tumor growth (n  1), or were deceased (n  5).
echnical aspects of cardiac MRI. Image quality was
ood or very good in 81% of cases, and most cases
ncluded interpretable cine SSFP, T1-TSE, and T2-TSE
maging of the mass. However, fewer cases (particularly
or those performed before 2004) included FPP (62%) orDE sequences (58%) (Table 3). Imaging parameters for wSE sequences varied among institutions; median values
range) for T1-TSE were: TE 15 ms (5.6 to 43 ms), TR
60 ms (411 to 1,967 ms); for T2-TSE: TE 80 ms (56 to
20 ms), TR 1,463 ms (727 to 5,625 ms). The most
ommon causes of fair or poor image quality were:
) blurring of cardiac structures and tumor as well as
uboptimal suppression of signal from the blood pool on
SE images, often seen when half-Fourier acquisition
ingle-shot turbo spin echo sequence was employed; and
) MDE imaging with incorrect inversion time resulting
n inadequate suppression of signal from normal myocar-
ium. The latter was most often seen when inversion
ime mapping or phase sensitive inversion recovery tech-
iques were not employed.
The incidence of reported technical problems and
dverse events was low (4%). All 3 patients with adverse
vents during the cardiac MRI examination were infants
Technical CharacteristicsTable 3 Technical Characteristics
Scanner
General Electric 29 (37)
Philips 33 (42)
Siemens 16 (21)
Sedation for cardiac MRI
No sedation 21 (27)
General anesthesia 49 (63)
IV sedation 7 (9)
Anxiolysis 1 (1)
Reported technical problems 4 (5)
Adverse events
Hypotension under general anesthesia 2 (3)
SVT requiring cardioversion 1 (1)
Tissue source
Resection 58 (74)
Biopsy 18 (23)
TS diagnosis 2 (3)
Image quality
Very good 25 (32)
Good 38 (49)
Fair 13 (17)
Poor 2 (3)
Imaging sequences of interpretable quality
Cine SSFP 72 (92)
Pre-contrast T1-TSE 73 (94)
Post-contrast T1-TSE 44 (56)
Pre-contrast T2-TSE 57 (73)
MRA 21 (27)
FPP 48 (62)
Pre-2004 FPP (n  18) 4 (22)
2004 FPP (n  60) 44 (73)
MDE 45 (58)
Pre-2004 MDE (n  18) 6 (33)
2004 MDE (n  60) 39 (65)
Values are n (%).
IV  intravenous; MRA  magnetic resonance angiography; MRI  magnetic resonance
imaging; SVT  supraventricular tachycardia; T1-TSE  T1-weighted turbo (fast) spin echo;
T2-TSE  T2-weighted turbo (fast) spin echo; other abbreviations as in Table 1.ith either large fibroma or rhabdomyoma who under-
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infants had transient hypotension requiring fluid and/or
dopamine administration after induction of anesthesia.
The other patient, who had a large left ventricular
rhabdomyoma resulting in hypoplastic left heart physiol-
ogy, required cardioversion for symptomatic supraven-
tricular tachycardia during the cardiac MRI. This patient
ultimately died while waiting for a heart transplant.
Tumor type and location. Tumors were found in all
cardiac chambers and extracardiac locations (Fig. 1). The
most common tumor locations were within the ventricular
Figure 1 Locations of Cardiac Tumors
Schematic depiction of locations of cardiac tumors in 78 patients. Ratios refer to
by the total number of cases with same tumor type. Note that 1 tumor might involmyocardium (right or left ventricular free wall or ventricular
septum). Tumor types are listed in Table 2.
Signal characteristics. Gross tumor features and signal
characteristics are summarized in Tables 4 and 5, respec-
tively. Figure 2 depicts tumor/myocardial signal intensity
ratio on MDE and FPP sequences.
Diagnostic accuracy. With pre-defined diagnostic criteria,
the 3 reviewers who were blinded to the histologic diagnosis
classified the tumor type in each case. Of the 78 cases, 76
(97%) were correctly diagnosed, with 43 (55%) having a
single correct diagnosis, and 33 (42%) having the correct
r of cases of each tumor type in this location divided
eral locations. LV  left ventricle; RV  right ventricle.numbe
ve sev
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August 30, 2011:1044–54 Magnetic Resonance Imaging Evaluation of Cardiac Tumorsdiagnosis as part of a differential diagnosis. Of the 34 cases
with a differential diagnosis, 16 had 2 possible diagnoses,
and 18 had 3 possible diagnoses.
There were 2 cases of incorrect diagnosis, and both had
an atypical appearance on cardiac MRI images. The first
misdiagnosis was a fibroma in a right atrial location,
incorrectly diagnosed as teratoma (Fig. 3). The location of
the tumor was atypical, and it was difficult to distinguish
right atrial from mediastinal location on the basis of the
images. Cine SSFP imaging, T1-TSE, T2-TSE, and FPP
imaging were performed with good image quality. However,
MDE image quality was nondiagnostic. The second misdi-
agnosis was a rhabdomyoma that was thought to be either
malignancy or thrombus (Online Fig. 1). This tumor had
the appearance of a small, indistinct mass at the junction
between the inferior right ventricular free wall and the
septum. Cine SSFP, T1-TSE, FPP, and MDE imaging
were performed with good image quality, but T2-TSE
imaging was not performed.
Gross Tumor CharacteristicsTable 4 Gross Tumor Characteristics
Tumor Type n
Largest
Dimension,
cm
Single
Tumors
Single Lobu
Tumors
Fibroma 30 5.3 (3.3–9.0) 30 (100) 2 (7)
Rhabdomyoma 14 2.9 (0.9–5.2) 12 (86) 1 (7)
Malignant 12 7.4 (3–23) 11 (92) 1 (8)
Hemangioma 9 3 (1.4–4.4) 10 (100) 0 (0)
Thrombus 4 3.6 (1.1–6.0) 3 (75) 0 (0)
Myxoma 3 (1.8–3.3) 3 (100) 1 (33)
Teratoma 2 (3.5–7.8) 2 (100) 0 (0)
Paraganglioma 1 3.7 1 (100) 0 (0)
Papillary fibroelastoma 1 1.8 1 (100) 0 (0)
Pleuropericardial cyst 1 6.3 1 (100) 0 (0)
Purkinje cell tumor 1 0.7 1 (100) 0 (0)
Values are n, mean (range), or n (%). *Identification of multiple lobules within tumors depen
†Hemodynamic abnormality refers to inflow or outflow obstruction or valve regurgitation related t
Tumor/Myocardium Signal IRTable 5 Tumor/Myocardium Signal IR
Pathology Diagnosis n Cine SSFP IR Pre-Co
Fibroma 30 1.0 (0.5–1.7) 1.0
Rhabdomyoma 14 1.5 (0.5–2.7) 1.1
Malignant tumor 12 1.4 (0.8–2.4) 1.3
Hemangioma 9 1.8 (1.0–2.5) 1.2
Thrombus 4 1.4 (0.9–1.7) 1.1
Myxoma 3 (1.3–3.0)
Teratoma 2 (2.4–2.5)
Paraganglioma 1 1.7
Papillary fibroelastoma 1 1.4
Pleuropericardial cyst 1 2.7
Purkinje cell tumor 1 —Values are n or median (range).
IR  intensity ratio (ratio of tumor signal intensity to adjacent myocardium signal intensity); SSFP  sMore complete examination and better image quality
were 2 factors that improved the likelihood of a single
accurate diagnosis. The majority (40 of 47; 85%) of cases
with complete examination had a single correct diagnosis
as compared with only 3 of 31 (10%) of those with an
incomplete study (p  0.0001). With respect to image
quality, 19 of 25 (76%) of the studies with very good
image quality had a single correct diagnosis as compared
with 17 of 38 (45%) of studies with good image quality
and 7 of 15 (47%) of studies with fair image quality
(p  0.04). However, a higher image quality grade was
not associated with better diagnostic accuracy when
controlling for completeness of examination. Of the 47
complete studies, 34 of 41 (83%) with good image
quality versus 6 of 6 (100%) studies with fair image
quality had a single accurate diagnosis (p  0.57).
Furthermore, of the 31 incomplete studies, 2 of 22 (9%)
with good image quality versus 1 of 9 (11%) with fair
image quality had a single accurate diagnosis (p  1.0).
Multiple
Tumors
Heterogenous
Appearance
Pericardial
Effusion
Pleural
Effusion
Hemodynamic
Abnormality†
0 (0) 17 (57) 14 (47) 2 (7) 12 (40)
1 (7) 0 (0) 3 (21) 1 (7) 9 (64)
1 (8) 7 (58) 5 (42) 5 (42) 9 (75)
0 (0) 8 (89) 2 (22) 0 (0) 7 (78)
1 (25) 1 (25) 1 (25) 3 (75) 1 (25)
0 (0) 3 (100) 0 (0) 0 (0) 1 (33)
0 (0) 1 (50) 2 (100) 0 (0) 1 (100)
0 (0) 1 (100) 0 (0) 0 (0) 0 (0)
0 (0) 0 (0) 0 (0) 0 (0) 1 (100)
0 (0) 1 (100) 0 (0) 0 (0) 0 (0)
0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
ood image resolution and type of sequences performed and thus might be underestimated.
mor.
T1 IR T2 IR FPP IR MDE IR
.1) 1.1 (0.3–3.6) 0.3 (0.2–0.6) 6.7 (1.9–20)
.3) 1.7 (1.0–2.9) 0.4 (0.3–0.7) 1.0 (0.8–1.2)
.4) 2.4 (0.9–6.1) 0.5 (0.3–0.9) 1.3 (0.5–5.3)
.5) 1.4 (0.9–6.6) 1.5 (1.0–3.1) 6 (3.9–8.6)
.4) 1.3 (0.3–0.6) (0.7–0.9)
.8) (1.7–2.1) (0.3–0.4) (0.7–4.8)
.7) 2.5 0.2 1.4
2.1 2.4 5.3
— — 1
5.2 — 3
— — —lated
*
ds on g
o the tuntrast
(0.4–1
(0.9–1
(0.7–2
(0.8–1
(0.8–1
(0.8–1
(0.8–2
1.2
—
1.4
3.8teady state free precession.
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Magnetic Resonance Imaging Evaluation of Cardiac Tumors August 30, 2011:1044–54Of the 12 malignant tumors in this series, 3 were primary
cardiac malignancies, and the remainder had a history of
extracardiac malignancy. All malignant cardiac masses were
correctly diagnosed as malignancy (n  11) or possible
alignancy (n  1).
ardiac MRI characteristics of tumors. The cardiac MRI
haracteristics that best define the following tumors are
isted herein.
FIBROMA. For fibroma (Fig. 4), characteristics include:
1) intramyocardial location involving the ventricular septum
or free wall (with the exception of the right atrial fibroma
shown in Fig. 3); 2) well-defined borders with a thin rim of
yocardium; 3) strong hyperenhancement on MDE imag-
ng with or without a hypoenhancing (dark) core;
) hypointense on FPP or magnetic resonance angiogram;
Figure 2 Scatterplots of Tumor/Myocardium
Signal Intensity Ratios
(A) Signal intensity ratio of myocardial delayed enhancement (MDE) imag-
ing. Note that signal intensity ratio is higher in fibroma and in tumors with
ample vascular supply (e.g., hemangioma and paraganglioma) as compared
with rhabdomyoma and thrombus. Some malignant tumors also have a high
signal intensity ratio; (B) signal intensity ratio of first pass myocardial per-
fusion. Note that signal intensity ratio is higher in tumors with ample vascu-
lar supply (e.g., hemangioma and paraganglioma) as compared with all
other tumor types.nd 5) heterogeneous appearance on T1- and T2-weightedSE sequences with variable areas of slightly hypo- or
yperintense areas.
VASCULAR TUMORS. For vascular tumors (Fig. 5), charac-
eristics include: 1) clearly positive (iso- or hyperintense)
PP sequence; 2) variable, often weak enhancement (iso- or
ildly hyperintense) on MDE imaging; and 3) variable
ocation. Note that imaging sequences currently available by
ardiac MRI might not allow distinction among benign
ascular tumors (e.g., hemangioma), malignant vascular
umors (e.g., angiosarcoma), vascular malformations, and
umors with ample vascular supply (e.g., paraganglioma).
owever, our single case of angiosarcoma (included in the
ategory of malignant tumors) was hypo-perfused on first
ass perfusion imaging.
RHABDOMYOMA. For rhabdomyoma (Online Fig. 2), char-
acteristics include: 1) intramyocardial or intracavitary loca-
tion, attached to the myocardium; 2) hypointense on FPP
sequence; 3) isointense on MDE imaging; 4) mildly hyper-
intense on T2W-TSE imaging; and 5) homogenous ap-
pearance on all sequences.
TERATOMA. For teratoma (Fig. 6), characteristics include:
) intrapericardial, often compressing the superior vena cava
nd/or right atrium; 2) multilocular, bosselated mass with
olid and cystic areas; and 3) hypointense on FPP. Note the
imilarity of the intrapericardial teratoma shown in Fig. 6
ith the hemangioma shown in Fig. 5. One distinguishing
haracteristic was the presence of avid perfusion in the
emangioma and absence of detectable perfusion in the
eratoma.
PLEUROPERICARDIAL CYST. For pleuropericardial cyst,
characteristics include: 1) pleuropericardial location, often
in the right cardio-phrenic angle; 2) smooth-walled and
well-defined; 3) hyperintense on cine SSFP; 4) strongly
hyperintense on T2-TSE; and 5) hypointense on FPP.
MYXOMA. For myxoma (Online Fig. 3), characteristics in-
clude: 1) irregular border, pedunculated, and mobile;
2) hyperintense on T2-TSE; 3) hypointense on FPP;
4) heterogeneous enhancement (iso- or hyperintense) on
MDE imaging; and 5) location in any cardiac chamber
(commonly left or right atrium, or atrial septum).
FIBROELASTOMA. For fibroelastoma, characteristics in-
clude: pedunculated, mobile, endocardial, or valvular mass.
Other signal characteristics have not been well defined.
MALIGNANT CARDIAC TUMORS. For malignant cardiac tu-
mors (Online Fig. 4), characteristics include: 1) history of
extracardiac malignancy; 2) infiltrative appearance, de-
fined as a) crossing an annular or tissue plane within the
heart, b) involving both cardiac and extracardiac struc-
tures, or c) appearance of linear growth through a large
vessel such as the superior or inferior vena cava; and
3) variable (hypo-, iso-, or hyperintense) appearance on
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aging. If hyperintense on MDE imaging, the appearance
is heterogeneous (in contrast to the fibroma, which is
strong and well defined).
Discussion
Although echocardiography is the conventional screening
method for intracardiac masses and tumors, cardiac MRI
can provide better imaging of tumor size and location,
adjacent mediastinal structures, and tumor signal charac-
teristics (11). Despite the rare occurrence of cardiac
tumors, cases evaluated by cardiac MRI have been re-
ported in the published data (3,4,7,12,13). On the basis
of this initial experience, we found that certain charac-
teristics on cardiac MRI are likely predictive of patho-
logic diagnosis; however, this impression has not been
tested rigorously. The present study provides the largest
database of pediatric cardiac tumors with cardiac MRI
and tissue diagnoses and is also the first to examine the
utility of current cardiac MRI techniques in this uncom-
mon condition.
In nearly all of our cases, the correct diagnosis was either
selected or included in a differential diagnosis on the basis of
the criteria outlined in Table 1. Importantly, no malignant
Figure 3 Misdiagnosed Fibroma
Misdiagnosed large right atrial (RA) fibroma. Note the unusual RA location of the t
(B) coronal plane T1-weighted turbo (fast) spin echo (T1-TSE) showing isointense
ing low or absent perfusion except for a thin peripheral rim; and (D) contrast-enha
low or absent perfusion of the tumor. Myocardial delayed enhancement imaging wtumor was misdiagnosed as benign on the basis of thepre-defined criteria. However, malignancy was included as
part of the differential diagnosis for several benign tumors,
demonstrating that malignancy might be difficult to exclude,
even in cases with excellent image quality. In addition,
cardiac MRI does not distinguish between specific types of
highly vascular tumors such as hemangioma, vascular tu-
mors with malignant potential (e.g., angiosarcoma), some
vascular malformations, and some neuroendocrine tumors
(e.g., paraganglioma). Because of the possibility of malig-
nant potential, consideration should be given to resection of
any tumor with cardiac MRI evidence of a strong vascular
supply (iso- or hyperintense on FPP).
The 2 factors that best predicted diagnostic accuracy were
completeness of the examination and image quality. A
comprehensive examination that includes all key imaging
sequences was the most important determining factor with
regard to arriving at a correct single diagnosis. This obser-
vation is explained, at least in part, by the study design,
which excluded nondiagnostic images. Therefore, a system-
atic approach to the cardiac MRI examination of pediatric
patients with cardiac tumors is essential to maximize the
diagnostic potential of the test. On the basis of the experi-
ence with this cohort, the following imaging sequences are
recommended in pediatric patients evaluated for a cardiac
arrows). (A) Hyperintense signal on T2-weighted turbo (fast) spin echo (T2-TSE);
(C) strongly hypointense signal on first pass myocardial perfusion (FPP) indicat-
agnetic resonance angiogram (MRA) showing hypointense signal consistent with
performed. Ao  aorta; LA  left atrium.umor (
signal;
nced m
as nottumor or mass:
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to characterize tumor location, relation to neighboring
structures, and to assess for potential interference with
Figure 4 LV Fibroma
Typical large fibroma involving the anterior wall of the left ventricle (LV). (A) Isointense
and (D) strongly hyperintense on myocardial delayed enhancement (MDE) with a centr
Figure 5 Right Atrial Hemangioma
(A) Iso- to slightly hyperintense signal on T1-TSE; (B) strongly hyperintense signal
with avid perfusion of the tumor; and (D) hyperintense signal on post-contrast T1-blood flow or ventricular function. Suggested imaging
planes include axial and oblique planes across the tumor
as well as assessment of biventricular size and function.
l on T1-TSE; (B) slightly hyperintense on T2-TSE; (C) strongly hypointense on FPP;
core. RV  right ventricle; other abbreviations as in Figure 3.
-TSE; (C) inhomogeneous, strongly hyperintense signal on FPP
bbreviations as in Figure 3.signa
al darkon T2
TSE. A
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aging plane should include the tumor as well as
uninvolved ventricular myocardium.
3. T2-TSE with fat suppression.
4. Contrast FPP.
5. MDE imaging.
When an intracardiac thrombus is suspected, post-
contrast imaging with an MDE sequence with a long
inversion time (600 ms) is recommended (14). We have
not found additional benefit from post-contrast T1- or
T2-TSE sequences. Additional imaging sequences (e.g.,
flow velocity mapping, magnetic resonance angiography,
coronary artery imaging to assess relationship to tumor)
might be obtained to address specific additional diagnos-
tic questions.
From a technical perspective, pitfalls were noted most
often with TSE and MDE sequences. In some cases TSE
images suffered from low signal/noise ratio and from
blurring of the boundaries between tumor tissue and
adjacent normal tissue. These problems were most fre-
quently encountered in single-shot TSE sequences that
were not ECG-gated and had relatively low spatial
resolution. Superior results were usually obtained by
Figure 6 Intrapericardial Teratoma
(A) Cine steady-state free precession (SSFP) cine in the coronal plane showing a
tense signal; (C) hyperintense signal on T2-TSE; (D) strongly hypointense signal o
Note the similar location and appearance of the teratoma compared with the hem
pulmonary artery; SVC  superior vena cava; other abbreviations as in Figure 3.performing TSE with ECG-gating and the use of thedouble inversion recovery technique to null the signal
from blood. A TE of approximately 10 ms should be used
for T1-weighting and approximately 70 ms for T2-
weighting. The TR, which is confined to multiples of the
cardiac cycle duration (R-R interval), is best set to 1 or 2
R-R intervals at heart rates 100 beats/min and 2 to 3
R-R intervals at faster heart rates to allow sufficient time
for adequate signal recovery. Minimizing slice thickness
while maintaining adequate signal/noise ratio and orien-
tation of the imaging plane to maximize through-plane
blood flow will also optimize image quality. With regard
to MDE imaging, the most prevalent problem was
inadequate nulling of signal from normal myocardium
due to improper selection of the inversion time. Use of an
inversion time mapping sequence and a phase-sensitive
MDE sequence can minimize this problem.
Previous studies in adult patients have evaluated char-
acteristics of cardiac and paracardiac masses by cardiac
MRI with pathology correlation. In the largest study of
its kind, Hoffman et al. (15) reviewed cardiac MRI
characteristics of masses in 55 adults with confirmed
tumor histology. They found that tumor location, tissue
composition (homogenous vs. heterogeneous), and pres-
ulticystic tumor (arrow); (B) axial plane T1-TSE showing inhomogeneous isoin-
and (E) hypointense signal on myocardial delayed enhancement (MDE) imaging.
a (Fig. 5) with the exception of brisk perfusion of the hemangioma. MPA  mainlarge m
n FPP;
angiomence of pericardial or pleural effusion were predictors of
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predicting malignancy with an area under the receiver-
operator characteristic curve between 0.88 and 0.92.
However, although there were several good predictors of
tumor type, no single predictor or combination of pre-
dictors could provide 100% sensitivity and specificity.
Thus, although cardiac MRI provides important clinical
information on cardiac tumors, malignancy cannot always
be definitively excluded, requiring tissue diagnosis in
certain cases—similar to our experience.
Another noteworthy observation is that the frequencies
of cardiac tumors in this cohort do not reflect their overall
incidence in the general population of pediatric patients.
For example, in a recent review of the database at
Children’s Hospital Boston, rhabdomyoma represented
61% of cardiac tumors diagnosed from 1980 through
2005 (16). However, rhabdomyoma was present in only
18% of cases in our series. This apparent discrepancy is
explained by referral bias, because in the majority of cases
rhabdomyoma is easily diagnosed by echocardiography
on the basis of the typical appearance of multiple tumors
and/or a diagnosis of tuberous sclerosis (17,18). Conse-
quently, patients with typical rhabdomyomas are not
referred for cardiac MRI. The rhabdomyomas included in
this series were atypical in that they were solitary, large
tumors that were difficult to distinguish from other
cardiac tumors by echocardiography.
Study limitations. Although we obtained pathology re-
ports on all cases, the histology was not reviewed at a core
laboratory. The retrospective nature of the study pre-
cluded a uniform imaging protocol, resulting in variable
image quality and completeness of examinations. For
example, variations in TE or TR might have resulted in
variable T1- and T2-weighting of TSE images. Also, the
timing of the cardiac MRI with respect to diagnosis and
treatment might have impacted some of the data in
specific cases. For example, a few patients had a partial
tumor resection before cardiac MRI examination; thus
the size of the native tumor, its hemodynamic impact, or
the presence of a pericardial or pleural effusion might
have been altered. Finally, as noted in the preceding text,
the distribution of frequencies of tumors included in this
cohort is not representative of that in the general popu-
lation of children.
Conclusions
With a set of pre-defined diagnostic criteria, cardiac MRI
imaging of cardiac tumors in children is predictive of tissue
diagnosis. More complete examinations and better image
quality result in improved diagnostic accuracy.Reprint requests and correspondence: Dr. Rebecca S. Ber-
oukhim, Department of Cardiology, Children’s Hospital Boston,
300 Longwood Avenue, Boston, Massachusetts 02115. E-mail:
rebecca.beroukhim@cardio.chboston.org.
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